clinic-based hpv and covid-19 vaccine promoting intervention for afam adolescents in alabama

Conditions: Vaccine Refusal

Summary: in this 30-month study, the investigators propose to develop a culturally appropriate vaccine confidence intervention, targeting positive change related to hpv vaccine uptake behavior and reducing sentiments of hesitancy towards a covid-19 vaccine, that can be seamlessly integrated into the existing environment of pediatric and family practice clinics in rural alabama. to do so, the investigators will first assess stakeholders' knowledge, sentiments, and beliefs related to vaccination in general, a covid-19 vaccination, and the hpv vaccination. the investigators will also assess stakeholders' perceptions of barriers to vaccination that exist in rural alabama. this will occur in aim 1. then, in aim 2, the investigators will use these data to inform the development of a non-invasive, modular synchronous counseling intervention targeting 15-17 year old adolescents (rationale for this age range presented later in this proposal). after the intervention has been finalized, in our final aim, aim 3, we will conduct a hybrid type 1 effectiveness-implementation cluster randomized control trial to assess intervention acceptability and feasibility (n=4 clinics; n=120 adolescents), while also assessing for a "clinical signal" of effectiveness. to support dissemination and scale up, also during aim 3, we will document implementation contexts to provide real-world insight. to do this, the investigators will conduct in-depth interviews with the same groups of stakeholders that we interviewed in aim 1.

in this 30-month study, the investigators propose to develop a culturally appropriate vaccine confidence intervention, targeting positive change related to hpv vaccine uptake behavior and reducing sentiments of hesitancy towards a covid-19 vaccine, that can be seamlessly integrated into the existing environment of pediatric and family practice clinics in rural alabama. to do so, the investigators will first assess stakeholders' knowledge, sentiments, and beliefs related to vaccination in general, a covid-19 vaccination, and the hpv vaccination. the investigators will also assess stakeholders' perceptions of barriers to vaccination that exist in rural alabama. this will occur in aim 1. then, in aim 2, the investigators will use these data to inform the development of a non-invasive, modular synchronous counseling intervention targeting 15-17 year old adolescents (rationale for this age range presented later in this proposal). after the intervention has been finalized, in our final aim, aim 3, we will conduct a hybrid type 1 effectiveness-implementation cluster randomized control trial to assess intervention acceptability and feasibility (n=4 clinics; n=120 adolescents), while also assessing for a "clinical signal" of effectiveness. to support dissemination and scale up, also during aim 3, we will document implementation contexts to provide real-world insight. to do this, the investigators will conduct in-depth interviews with the same groups of stakeholders that we interviewed in aim 1.

Eligibility criteria:
inclusion criteria: * ages 15-26 years * have not completed hpv vaccination schedule * located in a rural, non-urban setting * able to provide informed consent exclusion criteria: * doe not meet inclusion criteria